Cargando…

New Therapeutic Agent against Arterial Thrombosis: An Iridium(III)-Derived Organometallic Compound

Platelet activation plays a major role in cardio and cerebrovascular diseases, and cancer progression. Disruption of platelet activation represents an attractive therapeutic target for reducing the bidirectional cross talk between platelets and tumor cells. Platinum (Pt) compounds have been used for...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsia, Chih-Wei, Velusamy, Marappan, Tsao, Jeng-Ting, Hsia, Chih-Hsuan, Chou, Duen-Suey, Jayakumar, Thanasekaran, Lee, Lin-Wen, Li, Jiun-Yi, Sheu, Joen-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5751219/ https://www.ncbi.nlm.nih.gov/pubmed/29206177 http://dx.doi.org/10.3390/ijms18122616

Ejemplares similares

Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation
por: Shyu, Kou-Gi, et al.
Publicado: (2018)

Novel iridium (III)-derived organometallic compound for the inhibition of human platelet activation
por: Shyu, Kou-Gi, et al.
Publicado: (2019)

Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation
por: Shyu, Ren-Shi, et al.
Publicado: (2018)

Esculetin, a Coumarin Derivative, Prevents Thrombosis: Inhibitory Signaling on PLCγ2–PKC–AKT Activation in Human Platelets
por: Hsia, Chih-Wei, et al.
Publicado: (2019)

Novel Therapeutic Agent against Platelet Activation In Vitro and Arterial Thrombosis In Vivo by Morin Hydrate
por: Hsia, Chih-Wei, et al.
Publicado: (2018)

A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2017)

Author Correction: A novel ruthenium (II)-derived organometallic compound, TQ-6, potently inhibits platelet aggregation: Ex vivo and in vivo studies
por: Hsia, Chih-Hsuan, et al.
Publicado: (2020)

Structure-Antiplatelet Activity Relationships of Novel Ruthenium (II) Complexes: Investigation of Its Molecular Targets
por: Hsia, Chih-Hsuan, et al.
Publicado: (2018)

Suppression of Human Platelet Activation via Integrin α(IIb)β(3) Outside-In Independent Signal and Reduction of the Mortality in Pulmonary Thrombosis by Auraptene
por: Hsia, Chih-Wei, et al.
Publicado: (2019)

Modulation of human platelet activation and in vivo vascular thrombosis by columbianadin: regulation by integrin α(IIb)β(3) inside-out but not outside-in signals
por: Hou, Shaw-Min, et al.
Publicado: (2020)

Synthetic Ruthenium Complex TQ-6 Potently Recovers Cerebral Ischemic Stroke: Attenuation of Microglia and Platelet Activation
por: Hsia, Chih-Hsuan, et al.
Publicado: (2020)

Mechanisms of TQ-6, a Novel Ruthenium-Derivative Compound, against Lipopolysaccharide-Induced In Vitro Macrophage Activation and Liver Injury in Experimental Mice: The Crucial Role of p38 MAPK and NF-κB Signaling
por: Hsia, Chih-Hsuan, et al.
Publicado: (2018)

Structure–Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic Diseases
por: Yang, Chih-Hao, et al.
Publicado: (2018)

Antiplatelet Activity of a Newly Synthesized Novel Ruthenium (II): A Potential Role for Akt/JNK Signaling
por: Khamrang, Themmila, et al.
Publicado: (2017)

Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen–integrin α(II) (b)β(3) binding in human platelets
por: Hsia, Chih‐Hsuan, et al.
Publicado: (2018)

A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice
por: Sheu, Joen-Rong, et al.
Publicado: (2017)

Author Correction: A novel indication of platonin, a therapeutic immunomodulating medicine, on neuroprotection against ischemic stroke in mice
por: Sheu, Joen-Rong, et al.
Publicado: (2020)

Possible Molecular Targets of Novel Ruthenium Complexes in Antiplatelet Therapy
por: Jayakumar, Thanasekaran, et al.
Publicado: (2018)

Neuroprotection by the Traditional Chinese Medicine, Tao-Hong-Si-Wu-Tang, against Middle Cerebral Artery Occlusion-Induced Cerebral Ischemia in Rats
por: Wu, Chih-Jen, et al.
Publicado: (2011)

Decreased Human Platelet Activation and Mouse Pulmonary Thrombosis by Rutaecarpine and Comparison of the Relative Effectiveness with BAY11-7082: Crucial Signals of p38-NF-κB
por: Huang, Wei-Chieh, et al.
Publicado: (2022)

Mechanisms of glabridin inhibition of integrin α(IIb)β(3) inside-out signals and NF-κB activation in human platelets
por: Huang, Wei-Chieh, et al.
Publicado: (2023)

Targeting MAPK/NF-κB Pathways in Anti-Inflammatory Potential of Rutaecarpine: Impact on Src/FAK-Mediated Macrophage Migration
por: Jayakumar, Thanasekaran, et al.
Publicado: (2021)

Myricetin as a promising inhibitor of platelet fibrinogen receptor in humans
por: Chang, Yi, et al.
Publicado: (2023)

Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways
por: Hsia, Chih-Hsuan, et al.
Publicado: (2021)

Corrigendum to “Auraptene, a Monoterpene Coumarin, Inhibits LTA-Induced Inflammatory Mediators via Modulating NF-κB/MAPKs Signaling Pathways”
por: Hsia, Chih-Hsuan, et al.
Publicado: (2022)

Glabridin, a Bioactive Flavonoid from Licorice, Effectively Inhibits Platelet Activation in Humans and Mice
por: Chung, Chi-Li, et al.
Publicado: (2022)

Activation of Nrf2 by Esculetin Mitigates Inflammatory Responses through Suppression of NF-κB Signaling Cascade in RAW 264.7 Cells
por: Jayakumar, Thanasekaran, et al.
Publicado: (2022)

Regulation of Human Platelet Activation and Prevention of Arterial Thrombosis in Mice by Auraptene through Inhibition of NF-κB Pathway
por: Hsia, Chih-Wei, et al.
Publicado: (2020)

Cyclic nucleotides and mitogen-activated protein kinases: regulation of simvastatin in platelet activation
por: Lee, Ye-Ming, et al.
Publicado: (2010)

Anti-Inflammatory Mechanism of An Alkaloid Rutaecarpine in LTA-Stimulated RAW 264.7 Cells: Pivotal Role on NF-κB and ERK/p38 Signaling Molecules
por: Jayakumar, Thanasekaran, et al.
Publicado: (2022)

Andrographolide induces vascular smooth muscle cell apoptosis through a SHP-1-PP2A-p38MAPK-p53 cascade
por: Chen, Yu-Ying, et al.
Publicado: (2014)

Columbianadin Dampens In Vitro Inflammatory Actions and Inhibits Liver Injury via Inhibition of NF-κB/MAPKs: Impacts on (∙)OH Radicals and HO-1 Expression
por: Jayakumar, Thanasekaran, et al.
Publicado: (2021)

Innovative Targeting Strategies in Drug Therapy for Inflammatory Diseases: Mechanistic Approaches
por: Chou, Duen-Suey, et al.
Publicado: (2015)

Comparison of free radical formation induced by baicalein and pentamethyl-hydroxychromane in human promyelocytic leukemia cells using electron spin resonance
por: Huang, Yung-Kai, et al.
Publicado: (2014)

Analysis of Titin in Red and White Muscles: Crucial Role on Muscle Contractions Using a Fish Model
por: Wu, Ming-Ping, et al.
Publicado: (2018)

Effect of Antrodia camphorata on Inflammatory Arterial Thrombosis-Mediated Platelet Activation: The Pivotal Role of Protein Kinase C
por: Lu, Wan-Jung, et al.
Publicado: (2014)

Rutaecarpine, an Alkaloid from Evodia rutaecarpa, Can Prevent Platelet Activation in Humans and Reduce Microvascular Thrombosis in Mice: Crucial Role of the PI3K/Akt/GSK3β Signal Axis through a Cyclic Nucleotides/VASP—Independent Mechanism
por: Huang, Chun-Jen, et al.
Publicado: (2021)

Molecular Targets of Natural Products for Chondroprotection in Destructive Joint Diseases
por: Jayakumar, Thanasekaran, et al.
Publicado: (2020)

Mechanisms of Ascorbyl Radical Formation in Human Platelet-Rich Plasma
por: Shyu, Kou-Gi, et al.
Publicado: (2014)

Inhibitory Effects of Ketamine on Lipopolysaccharide-Induced Microglial Activation
por: Chang, Yi, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_05c0m36l8ttq07enquv22vmqan